EBF
EBF
EBF
European
Bioanalysis
Forum


EBF vzw is the registered non-profit organisation of the European Bioanalysis Forum

The Steering Committee

The day-to-day management, as well as the representation of the EBF as far as the day-to-day management and external representation is concerned is delegated from the Board of Directors to a Steering Committee (SC) elected amongst the Pharma members. SC composition reviewed and/or confirmed at strategy meeting of uneven year. The SC currently consists of the following 5 peopleĀ :

  • Marianne Scheel-Fjording, Novo Nordisk, Denmark
  • Magnus Knutsson, Ferring Pharmaceuticals, Denmark
  • Michaela Golob, Merck-Serono, Germany
  • Philip Timmerman, Janssen Research & Development, Belgium
  • Steve White, GSK, United Kingdom